Logo image of SMHN.DE

SUSS MICROTEC SE (SMHN.DE) Stock Fundamental Analysis

FRA:SMHN - DE000A1K0235 - Common Stock

25.56 EUR
+0.98 (+3.99%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SMHN. SMHN was compared to 53 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of SMHN get a neutral evaluation. Nothing too spectacular is happening here. SMHN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SMHN had positive earnings in the past year.
In the past year SMHN has reported a negative cash flow from operations.
SMHN had positive earnings in each of the past 5 years.
Each year in the past 5 years SMHN had a positive operating cash flow.
SMHN.DE Yearly Net Income VS EBIT VS OCF VS FCFSMHN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of SMHN (10.65%) is better than 68.33% of its industry peers.
With a decent Return On Equity value of 19.07%, SMHN is doing good in the industry, outperforming 68.33% of the companies in the same industry.
SMHN has a better Return On Invested Capital (14.62%) than 73.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SMHN is below the industry average of 15.12%.
The last Return On Invested Capital (14.62%) for SMHN is above the 3 year average (12.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.65%
ROE 19.07%
ROIC 14.62%
ROA(3y)10.08%
ROA(5y)8.26%
ROE(3y)18.63%
ROE(5y)15.03%
ROIC(3y)12.53%
ROIC(5y)11.25%
SMHN.DE Yearly ROA, ROE, ROICSMHN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 10.92%, SMHN is in line with its industry, outperforming 55.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SMHN has grown nicely.
With a Operating Margin value of 16.73%, SMHN perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
SMHN's Operating Margin has improved in the last couple of years.
SMHN has a worse Gross Margin (38.57%) than 66.67% of its industry peers.
SMHN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.73%
PM (TTM) 10.92%
GM 38.57%
OM growth 3Y20.89%
OM growth 5Y32.47%
PM growth 3Y59.64%
PM growth 5YN/A
GM growth 3Y3.64%
GM growth 5Y4.07%
SMHN.DE Yearly Profit, Operating, Gross MarginsSMHN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SMHN is creating some value.
The number of shares outstanding for SMHN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SMHN has about the same amount of shares outstanding.
The debt/assets ratio for SMHN has been reduced compared to a year ago.
SMHN.DE Yearly Shares OutstandingSMHN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SMHN.DE Yearly Total Debt VS Total AssetsSMHN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

SMHN has an Altman-Z score of 3.97. This indicates that SMHN is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.97, SMHN perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
SMHN has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
SMHN has a Debt to Equity ratio of 0.16. This is in the better half of the industry: SMHN outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 3.97
ROIC/WACC1.48
WACC9.89%
SMHN.DE Yearly LT Debt VS Equity VS FCFSMHN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SMHN has a Current Ratio of 2.78. This indicates that SMHN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.78, SMHN is in the better half of the industry, outperforming 71.67% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that SMHN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.42, SMHN is doing worse than 65.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 1.42
SMHN.DE Yearly Current Assets VS Current LiabilitesSMHN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The earnings per share for SMHN have decreased strongly by -28.57% in the last year.
Measured over the past years, SMHN shows a very strong growth in Earnings Per Share. The EPS has been growing by 90.26% on average per year.
SMHN shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.54%.
The Revenue has been growing by 15.85% on average over the past years. This is quite good.
EPS 1Y (TTM)-28.57%
EPS 3Y90.26%
EPS 5YN/A
EPS Q2Q%30.16%
Revenue 1Y (TTM)42.54%
Revenue growth 3Y19.2%
Revenue growth 5Y15.85%
Sales Q2Q%44.25%

3.2 Future

SMHN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.71% yearly.
Based on estimates for the next years, SMHN will show a small growth in Revenue. The Revenue will grow by 7.70% on average per year.
EPS Next Y-0.79%
EPS Next 2Y-5.1%
EPS Next 3Y3.71%
EPS Next 5YN/A
Revenue Next Year11.08%
Revenue Next 2Y0.98%
Revenue Next 3Y3.76%
Revenue Next 5Y7.7%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMHN.DE Yearly Revenue VS EstimatesSMHN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
SMHN.DE Yearly EPS VS EstimatesSMHN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.11, the valuation of SMHN can be described as reasonable.
100.00% of the companies in the same industry are more expensive than SMHN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.06. SMHN is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.43, the valuation of SMHN can be described as very reasonable.
SMHN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SMHN is cheaper than 90.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.69. SMHN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.11
Fwd PE 10.43
SMHN.DE Price Earnings VS Forward Price EarningsSMHN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SMHN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SMHN is cheaper than 98.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.68
SMHN.DE Per share dataSMHN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

SMHN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.1%
EPS Next 3Y3.71%

3

5. Dividend

5.1 Amount

SMHN has a Yearly Dividend Yield of 1.22%.
In the last 3 months the price of SMHN has falen by -34.83%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 1.40, SMHN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, SMHN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.22%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
SMHN.DE Yearly Dividends per shareSMHN.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

SMHN pays out 10.11% of its income as dividend. This is a sustainable payout ratio.
DP10.11%
EPS Next 2Y-5.1%
EPS Next 3Y3.71%
SMHN.DE Yearly Income VS Free CF VS DividendSMHN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M
SMHN.DE Dividend Payout.SMHN.DE Dividend Payout, showing the Payout Ratio.SMHN.DE Dividend Payout.PayoutRetained Earnings

SUSS MICROTEC SE

FRA:SMHN (9/5/2025, 7:00:00 PM)

25.56

+0.98 (+3.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners64.97%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap488.71M
Analysts78.82
Price Target45.37 (77.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.22%
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP10.11%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.16%
Min EPS beat(2)9.38%
Max EPS beat(2)24.95%
EPS beat(4)4
Avg EPS beat(4)13.01%
Min EPS beat(4)6.62%
Max EPS beat(4)24.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.91%
Min Revenue beat(2)13.58%
Max Revenue beat(2)18.24%
Revenue beat(4)3
Avg Revenue beat(4)12.34%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)19.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18%
PT rev (3m)-19.94%
EPS NQ rev (1m)-8.92%
EPS NQ rev (3m)-1.65%
EPS NY rev (1m)-9.03%
EPS NY rev (3m)-9.03%
Revenue NQ rev (1m)-0.97%
Revenue NQ rev (3m)23.19%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)4.1%
Valuation
Industry RankSector Rank
PE 8.11
Fwd PE 10.43
P/S 0.94
P/FCF N/A
P/OCF N/A
P/B 1.64
P/tB 1.78
EV/EBITDA 4.68
EPS(TTM)3.15
EY12.32%
EPS(NY)2.45
Fwd EY9.58%
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS27.19
BVpS15.56
TBVpS14.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.65%
ROE 19.07%
ROCE 22.83%
ROIC 14.62%
ROICexc 19.8%
ROICexgc 21.52%
OM 16.73%
PM (TTM) 10.92%
GM 38.57%
FCFM N/A
ROA(3y)10.08%
ROA(5y)8.26%
ROE(3y)18.63%
ROE(5y)15.03%
ROIC(3y)12.53%
ROIC(5y)11.25%
ROICexc(3y)19.25%
ROICexc(5y)16.63%
ROICexgc(3y)22.51%
ROICexgc(5y)19.72%
ROCE(3y)19.58%
ROCE(5y)17.57%
ROICexcg growth 3Y27.53%
ROICexcg growth 5Y45.15%
ROICexc growth 3Y30.15%
ROICexc growth 5Y45.63%
OM growth 3Y20.89%
OM growth 5Y32.47%
PM growth 3Y59.64%
PM growth 5YN/A
GM growth 3Y3.64%
GM growth 5Y4.07%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.51
Cap/Depr 195.49%
Cap/Sales 3.03%
Interest Coverage 338.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 1.42
Altman-Z 3.97
F-Score4
WACC9.89%
ROIC/WACC1.48
Cap/Depr(3y)83.54%
Cap/Depr(5y)97.9%
Cap/Sales(3y)2.08%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3Y90.26%
EPS 5YN/A
EPS Q2Q%30.16%
EPS Next Y-0.79%
EPS Next 2Y-5.1%
EPS Next 3Y3.71%
EPS Next 5YN/A
Revenue 1Y (TTM)42.54%
Revenue growth 3Y19.2%
Revenue growth 5Y15.85%
Sales Q2Q%44.25%
Revenue Next Year11.08%
Revenue Next 2Y0.98%
Revenue Next 3Y3.76%
Revenue Next 5Y7.7%
EBIT growth 1Y87.69%
EBIT growth 3Y44.1%
EBIT growth 5Y53.47%
EBIT Next Year16.05%
EBIT Next 3Y9.87%
EBIT Next 5Y9.95%
FCF growth 1Y-315.77%
FCF growth 3Y20.78%
FCF growth 5YN/A
OCF growth 1Y-139.34%
OCF growth 3Y11.23%
OCF growth 5YN/A